Subscriber access provided by UNIV OF NEW ENGLAND ARMIDALE
Functional Structure/Activity Relationships
The effects of astaxanthin and docosahexaenoic acid-acylated astaxanthin on Alzheimer's disease in APP/PS1 double transgenic mice Hongxia Che, Qian Li, Tiantian Zhang, Dandan Wang, Lu Yang, Jie Xu, Teruyoshi Yanagita, Changhu Xue, Yaoguang Chang, and YuMing Wang J. Agric. Food Chem., Just Accepted Manuscript • DOI: 10.1021/acs.jafc.8b00988 • Publication Date (Web): 25 Apr 2018 Downloaded from http://pubs.acs.org on April 26, 2018
Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.
is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.
Page 1 of 30
Journal of Agricultural and Food Chemistry
1
The effects of astaxanthin and docosahexaenoic acid-acylated astaxanthin on Alzheimer's disease
2
in APP/PS1 double transgenic mice
3
Hongxia Che, † Qian Li,† Tiantian Zhang,† Dandan Wang,† Lu Yang,† Jie Xu,† Teruyoshi Yanagita,‡ Changhu Xue,†,
4
⊥
⊥,*
Yaoguang Chang,†, * Yuming Wang†,
5
6
†
7
Shandong, China
8
‡
9
Saga University, Saga, 840-8502, Japan
10 11
College of Food Science and Engineering, Ocean University of China, Qingdao, 266003,
Laboratory of Nutrition Biochemistry, Department of Applied Biochemistry and Food Science,
⊥
Qingdao National Laboratory for Marine Science and Technology, Laboratory of Marine Drugs
& Biological products, Qingdao 266237, Shandong, China
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
12
ABSTRACT
13
Alzheimer's disease (AD) is a progressive neurodegenerative disorder with the characteristics of
14
senile plaques, neuro-inflammation, neurofibrillary tangles and destruction of synapse structure
15
stability. Previous studies have verified the protective effects of astaxanthin (AST). However,
16
whether synthesized docosahexaenoic acid-acylated AST diesters (AST-DHA) could delay AD
17
pathogenesis remains unclear. In the present study, APP/PSEN1 (APP/PS1) double transgenic
18
mice were administrated with AST and AST-DHA for 2 months. The results of radial 8-arm maze
19
and Morris water maze tests showed that AST-DHA exerted more significant effects than AST in
20
enhancing learning and memory levels of APP/PS1 mice. Further mechanical studies suggested
21
that AST-DHA was superior to AST in regulating the parameters of oxidative stress, reducing Tau
22
hyper-phosphorylation, suppressing neuro-inflammation and regulating inflammasome expression
23
and activation in APP/PS1 mice. The findings suggested AST-DHA attenuated cognitive disorders
24
by reducing pathological features in APP/PS1 mice, suggesting AST-DHA might be a potential
25
therapeutic agent for Alzheimer's disease.
26
KEYWORDS: Alzheimer's disease, astaxanthin, cognitive disorder, DHA-acylated AST esters,
27
neuro-inflammation
28
ACS Paragon Plus Environment
Page 2 of 30
Page 3 of 30
Journal of Agricultural and Food Chemistry
29
INTRODUCTION
30
The main pathological features of Alzheimer's disease (AD) are senile plaques,
31
neuro-inflammation, and destruction of synapse structure stability 1. There are very few AD drugs
32
on the present market, and these drugs only provide minimal symptomatic relief rather than
33
changes in disorder progression. Therefore, there is a great need for the therapeutic agents to
34
modify AD.
35
Astaxanthin (AST, Fig.1A), one of natural carotenoids, is widely present in marine organisms
36
such as shrimp, crab, krill, salmon, and microalgae 2. Importantly, the hydroxyl and keto moieties
37
on each ionone ring in AST imply its unique properties, especially, the ability to be esterified with
38
fatty acids to increase stability. Usually, AST occurs in esterified forms in nature, which is
39
chemically bound to various types of fatty acids such as oleic, eicosanoic, palmitic and stearic acid.
40
The AST in red crab langostilla (Pleuroncodes planipes) is comprised of about 70% diesters, 12%
41
monoesterified and 10% unesterified AST 3. Interestingly, it has been reported that the main
42
existing form of AST in Atlantic salmon is unesterified AST 4.
43
The bioactivity of AST is usually related to the reduced markers of oxidative damage.
44
Notably, recent evidence has emerged to indicate AST has a broad range of bioactivities including
45
anti-inflammatory, anti-apoptotic properties5. Moreover, AST plays a vital role in reducing
46
neurotoxicity in cell models of AD. In addition, AST could protect PC12 cells from Aβ-induced
47
cytotoxicity by up-regulating heme oxygenase-1 expression via ERK1/2 pathway5-6. Lobos et al.
48
provided further evidence to indicate that AST protected neurons from the noxious effects of Aβ
49
on mitochondrial ROS production and calcium dysregulation 7. Moreover, Cheong et al. have
50
verified that krill oil could enhance cognitive capability and modulate proteomic alterations in
51
brain of D-galactose induced aging mice 8.
52
Docosahexaenoic acid (DHA) is well known for various bioactivities 9. However, few study
53
focused on the protective effects of DHA-acylated AST ester. The APP/PSEN1 (APP/PS1)
54
transgenic mice, co-expressing the mutated Swedish APP gene and the exon-9-deleted variant of
55
the presenilin-1 (PS1) gene, are a successfully established transgenic animal models for AD
ACS Paragon Plus Environment
10
.
Journal of Agricultural and Food Chemistry
56
This model displays age-related plaque pathology, inflammatory response, oxidative damage,
57
age-related memory deficits11-12. In the present study, DHA-acylated AST diesters (AST-DHA)
58
was prepared, and APP/PS1 mice were used to compare the neuroprotective actions of AST and
59
AST-DHA and illustrate the possible underlying mechanisms.
60
MATERIALS AND METHODS
61
Chemicals and Reagents. Astaxanthin was obtained from Xinxiang Kesen Food Additives
62
Corporation (Tongxiang, Zhejiang, China). Aβ42 and Aβ40 ELISA kits were purchased from
63
Wuhan Uscn Life Science, Inc. (Wuhan, Hubei, China). The superoxide dismutase (SOD) assay
64
kit and nitric oxide (NO) assay kit were obtained from Nanjing Jiancheng Bioengineering Institute
65
(Nanjing, Jiangsu, China). The Nitric Oxide Synthase ELISA kit was from R&D System
66
(Minneapolis, MN, USA). p-Tau (Ser396) antibody, Tau antibody, p- GSK-3β (Y216+Y279)
67
antibody, GSK-3β antibody, CD11b antibody, GFAP antibody, IL-1β antibody, TNF-α antibody,
68
NLRP3 antibody, Caspase-1 antibody, Bax antibody, Bcl-2 antibody, caspase-9 antibody and
69
β-actin antibody were from Abcam (Cambridge, UK). Caspase-3 antibody and cleaved caspase-3
70
antibody were purchased from Cell Signaling Technology (Boston, USA).
71
Preparation of AST-DHA. AST-DHA (Fig.1A) was synthesized by 4-dimethylaminopyridine
72
catalyzed reaction of AST and DHA in the presence of 1-(3-Dimethylaminopropyl)-
73
3-ethylcarbodiimide hydrochloride system with nitrogen protection and light isolation according
74
to our previous study
75
25 ℃. The organic phase is recovered following the subsequent cleaning by 1 M hydrochloric acid,
76
saturated sodium bicarbonate and saturated sodium chloride. The organic mixture was evaporated
77
to dryness to obtain the AST-DHA (the purity > 90%), which was confirmed by HPLC-DAD
78
according to our previously published study.
79
Animals and Treatments. The animal study protocol was proved by the Animal Ethics
80
Committee of College of Food Science and Engineering of Ocean University of China. All the
81
animals were housed at the Laboratory Animal Facility at the Ocean University of China. The
82
research was conducted in accordance with the Guide for the Care and Use of Laboratory Animals
13
. Dichloromethane was added to the system after the reaction for 3 h at
ACS Paragon Plus Environment
Page 4 of 30
Page 5 of 30
Journal of Agricultural and Food Chemistry
83
(8 th edition, Institute of Laboratory Animal Resources on Life Sciences, National Research
84
Council, National Academy of Sciences, Washington DC). APP/PS1 transgenic mice (half male
85
and half female, weight of 20-25 g, aged 3 months) and eight of their wild-type littermates as
86
normal control group (Control) were obtained from Vital River Laboratories (Beijing, China). All
87
the mice were acclimatized for 1 week under a 12 h/12 h light/dark cycle at 23 °C with 60 ± 10%
88
humidity and provided with food and water ad libitum. The APP/PS1 transgenic mice were
89
randomly divided into Model group, AST group and AST-DHA group. All the mice were
90
supplemented with AIN-93G diet. The mice in AST and AST-DHA group were supplemented
91
with 0.2% AST and AST-DHA for 60 days, respectively. Then the water maze and radial 8-arm
92
maze tests were used to determine learning and memory levels. After that, the mice were
93
sacrificed by rapid decapitation. The cerebral cortex and hippocampus were separated from the
94
whole brain and weighed, then frozen with liquid nitrogen and stored at -80 °C until use.
95
Radial 8-Arm Maze Test. Spatial learning ability was determined by the radial 8-arm maze test
96
according to a previous method
97
radiating arms was placed at 1 m above the floor. A food cup was located at the end of each
98
radiating arm. Before training, the mice were deprived of half of the diet during the test. The baits
99
were restricted to the food cups. On the first two training days, the food pellet (45 mg) were
100
located at the food cups (eight trails) and central octagonal plate, the mice of the same group were
101
allowed to explore for food for 10 minutes together. On the third and fourth days, every mouse
102
was allowed to explore for food for 10 minutes. On the last day, four identical arms were baited
103
with a single 45 mg food pellet. Each trial continued until all four baits had been consumed or
104
until 10 minutes had elapsed. The numbers of reference memory errors and working memory
105
errors were conducted.
106
Water Maze Test. A circular stainless-steel pool with water (21-23 °C) was divided into four
107
quadrants. A circular black escape platform was located in the center of one quadrant. The mice
108
were trained to find the platform for five consecutive days. The time of finding the platform was
109
recorded as latency. The swim paths, distances, and latencies taken to the platform were
110
monitored with a video camera. Probe test without platform on the sixth day was used to
14
. The apparatus composed of a central octagonal plate and 8
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
111
determine spatial memory retention. The mice were placed in a position opposite the platform
112
location and allowed to swim for 60 sec. The number crossing over the previous position of the
113
platform and the time spent in the target quadrant were recorded as measures for spatial memory.
114
Immunohistochemistry. For paraffin sections, mice were killed and systemically perfused with
115
phosphate buffered saline (PBS) and 4% buffered paraformaldehyde through the left ventricle to
116
wash out blood cells. Then brain samples were collected, ehydrated and embedded in paraffin
117
using standard techniques. Sections (5 µm) were cut and deparaffinized. After incubation in
118
methanol containing 3% H2O2 for 15 minutes to block endogenous peroxidase activity,
119
nonspecific binding was done with universal blocking reagent for 30 minutes at room temperature.
120
The sections were incubated with the primary antibody against anti-Aβ (1:100; Servicebio),
121
anti-Iba1 (1:500; Servicebio) and anti-GFAP (1:500; Servicebio) at 4 °C for overnight followed by
122
several washing steps in PBS. Following incubation with biotinylated goat anti-rabbit IgG (1/200)
123
for 50 minutes, staining was done through incubation with peroxidase streptoavidin and
124
diaminobenzidine (DAB) at room temperature. Specific primary antibody was omitted in negative
125
control of the reactions. After counter staining nuclei with Mayer’s haematoxylin, the
126
immunopositive amyloid plaques in cortex and hippocampus were observed and counted. The
127
images were taken using a 5 MP Canon A95 camera integrated to the microscope and were
128
evaluated using image-J analysis.
129
Determination of Aβ Concentration by ELISA. Soluble and insoluble Aβ were extracted by the
130
previous method 15. Briefly, the right hippocampus was homogenized in TBS (pH8.0) containing
131
protease inhibitors. Samples were sonicated and centrifuged. The supernatant was used to
132
determine soluble Aβ40 and Aβ42 concentrations, whereas the TBS-insoluble pellet was firstly
133
sonicated in 2% SDS. To analyze the insoluble Aβ content, the SDS-insoluble pellet was
134
dissolved and sonicated in 70% formic acid. The extract was neutralized with 0.5 M Tris before
135
loading on the ELISA plate. The soluble/insoluble Aβ40 and Aβ42 levels were determined by
136
ELISA kits according to the manufacture’s instruction.
137
The Measurement of Oxidative Stress Parameters. The brain was prepared as a tissue
138
homogenate in 0.9% saline solution for the determination of protein concentration using a BCA
ACS Paragon Plus Environment
Page 6 of 30
Page 7 of 30
Journal of Agricultural and Food Chemistry
139
protein assay kit. The concentrations of nitric oxide (NO), inducible nitric oxide synthase (NOS)
140
and the activity of superoxide dismutase (SOD) were measured by the manufacture’s instruction.
141
Western Blot Analysis. The total protein and RNA of hippocampus were extracted by the
142
total-DNA-RNA-Protein kit. Equal amounts of protein were separated on 5-12% SDS-PAGE gels
143
and transferred to poly membranes. The membranes were incubated with antibodies against p-Tau
144
antibody (1:5000), Tau antibody (1:2000), p-GSK3β antibody (1:1000), GSK-3β antibody (1:500),
145
CD11b antibody (1:500), GFAP antibody (1:5000), IL-1β antibody (1:5000), TNF-α antibody
146
(1:200), NLRP3 (1:2000), Caspase 1 (1:1000) at 4 °C for overnight. After this, membranes were
147
incubated with specific horse radish peroxidase (HRP)-conjugated secondary antibodies (1:3000)
148
at room temperature 2 h and the blots were evaluated with chemiluminescent horseradish
149
peroxidase substrate. Then the blots were visualized by enhanced chemiluminescence (ECL)
150
substrate with UVP Auto Chemi Image system. Protein loading was evaluated by anti-β-actin
151
antibody (1:2000)..
152
Statistical Analysis. Data were expressed as mean ± standard deviation (SD). Statistical analyses
153
were evaluated by Student’s t test and Tukey’s test using SPSS 18.0. P < 0.05 was considered
154
statistically significant. Different letters indicated significant differences between each group.
155
RESULTS
156
AST and AST-DHA Improved Cognitive Disorder in APP/PS1 Mice. The spatial learning was
157
measures by radial 8-arm maze and Morris water maze tests. The radial 8-arm maze results
158
showed that APP/PS1 transgenic mice remarkably enhanced the number of reference memory
159
errors and working memory errors in comparison with non-APP/PS1 transgenic mice (Fig 1B and
160
C). Interestingly, AST and AST-DHA obviously reduced the number of reference memory errors
161
and working memory errors in APP/PS1 transgenic mice (Fig 1B and C), and no remarkable
162
difference was observed between these two groups.
163
The results of escape latency showed that the mice of control group had better performance
164
than APP/PS1 transgenic mice from day 1 to day 5, suggesting APP/PS1 transgenic mice
165
exhibited significant deficiency in spatial learning ability (Fig. 1D). The treatment with AST and
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
166
AST-DHA significantly improved the behaviors of APP/PS1 transgenic mice. Interestingly,
167
AST-DHA had a more significant effect than AST in alleviating spatial deficits of APP/PS1
168
transgenic mice.
169
The spatial memory results showed that APP/PS1 transgenic mice in model group spent less
170
time in the target quadrant and less crossing number than the control group (Fig. 1E and F). The
171
mice treated with AST and AST-DHA exerted similar effects with no statistical difference in
172
improving the time spent in the target quadrant. Interestingly, AST-DHA was superior to AST in
173
improving the number of crossing platform.
174
AST and AST-DHA Regulated Aβ Levels in APP/PS1 Mice. Brain sections were
175
immunostained with anti-Aβ antibody to show the Aβ deposition in the cortex and hippocampus
176
(Fig.2A), which was analyzed the number and area of plaques (Fig.2B and C). Compared with
177
control group, the amyloid plaques number in the cortex and hippocampus of APP/PS1 transgenic
178
mice were remarkably increased. Interestingly, AST and AST-DHA treatment could reduce
179
amyloid plaques number in cortex and hippocampus of APP/PS1 transgenic mice. Importantly,
180
AST-DHA was superior to AST in suppressing the number of amyloid plaques in cortex. The
181
results of quantitative analysis of Aβ showed that AST and AST-DHA suppressed the Aβ load.
182
AST-DHA exhibited more statistical effects than AST in reducing the Aβ load in hippocampus.
183
The soluble/insoluble Aβ40 and Aβ42 in the hippocampus were determined by ELISA kits,
184
and the results were shown in Fig. 3 A-D. The APP/PS1 transgenic mice exhibited higher soluble
185
and insoluble Aβ40 and Aβ42 levels than control group. Supplementation of AST and AST-DHA
186
exhibited a remarkable decrease of soluble and insoluble Aβ40 and Aβ42 levels in a certain degree.
187
Notably, AST-DHA exhibited more statistical effects than AST in reducing soluble Aβ40/Aβ42
188
levels. Unexpectedly, AST showed a better effect in reducing insoluble Aβ40 level than
189
AST-DHA group. No significant difference between AST and AST-DHA was observed in
190
inhibiting insoluble Aβ42 generation.
191
Following the soluble/insoluble Aβ40 and Aβ42 measurement, ADAM10, BACE1 and
192
Nicastrin were detected by western blotting. Compared with control group, the ADAM10 level of
ACS Paragon Plus Environment
Page 8 of 30
Page 9 of 30
Journal of Agricultural and Food Chemistry
193
model group was significantly decreased, and BACE1 and Nicastrin expression were obviously
194
increased. Notably, AST and AST-DHA treatment exerted similar effects in decreasing Nicastrin
195
level. However, there were no significant improvement for AST and AST-DHA in protein
196
expressions of ADAM10 and BACE1.
197
Effects of AST and AST-DHA on Oxidative Stress. Oxidative stress plays a central role in the
198
physiopathology of AD. Thus, we further investigated the effects of AST and AST-DHA on
199
oxidative stress to confirm the neuroprotective effects of AST and AST-DHA against AD. The
200
indexes of oxidative stress including SOD, NO, NOS were detected (Fig.4). Compared with
201
control group, the SOD activity in model group was significantly decreased, meanwhile, NOS
202
activity and NO level were obviously increased. Importantly, AST and AST-DHA treatment
203
significantly recovered the activity of SOD as well as declining NO and NOS levels, in which
204
AST-DHA was superior to AST in up-regulating SOD activity and down-regulating NO and NOS
205
levels.
206
The Effects of AST and AST-DHA on the Expression of p-GSK-3β and p-Tau. The effects of
207
AST and AST-DHA treatment on GSK-3β activity and p-Tau protein expression were evaluated
208
by Western blotting (Fig. 5A). Compared with the control group, the expression of p-GSK-3β
209
level in model group was obviously increased (p < 0.05, Fig. 5B). AST-DHA significantly
210
suppressed the expression of GSK-3β phosphorylation. Notably, AST treatment had no effects in
211
regulating the p-GSK-3β expression.
212
Following GSK3β activity, we also investigated the effects of dietary supplements of AST
213
and AST-DHA on p-Tau protein expression. The expression of p-Tau in model group was
214
remarkably increased compared with control group (Fig. 5C). Notably, dietary supplementation of
215
AST and AST-DHA could obviously reverse these changes, and AST-DHA exerted more
216
significant effects than AST in reducing the expression of p-Tau.
217
Inhibitory Effects of AST and AST-DHA on Neuro-inflammation in APP/PS1 Mice. The
218
neuro-inflammation induced by activated microglia and astrocytes is related to AD development.
219
To test the effects of AST and AST-DHA on neuro-inflammatory processes in APP/PS1
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
220
transgenic mice, immunohistochemical analysis and western blotting assay of astrogliosis and
221
microgliosis were performed using the astroglial marker (GFAP) and the microglial marker (Iba1
222
and CD11b, Fig. 6 A-D). The results showed that GFAP, Iba1 and CD11b were markedly
223
increased in the APP/PS1 transgenic mice but were significantly reduced in the AST and
224
AST-DHA treated mice both in immunohistochemical analysis and western blotting assay.
225
Importantly, AST-DHA was superior to AST in regulating the activation of microglia and
226
astrocytes.
227
Cytokines secreted by activated microglia and astrocytes are crucial in the inflammatory
228
processes of AD. The levels of IL-1β and TNF-α in AD mice were determined to investigate the
229
effects of AST and AST-DHA on cytokine production (Fig. 6 B, E and F). Compared with
230
no-transgenic mice, the expression of TNF-α in the APP/PS1 transgenic mice was markedly
231
increased. Notably, AST and AST-DHA supplementation could significantly reduce the
232
expression of TNF-α, and AST-DHA was superior to AST. Only AST-DHA significantly
233
suppressed the expression of IL-1β, and no statistical difference was found between AST group
234
and model group.
235
Inhibitory Effects of AST and AST-DHA on Inflammasome Activation in APP/PS1 Mice.
236
The NLRP3 inflammasome activation initiates an inflammatory response through caspase-1
237
activation, resulting in inflammatory cytokine IL-1β℃maturation and secretion. Therefore,
238
western blotting assay was performed to detect the NLRP3 inflammasome activation-related
239
proteins (Fig. 7). Unexpectedly, no statistical difference was observed in the expression of NLRP3
240
in these four groups. Compared with the control group, the expression of ASC in APP/PS1
241
transgenic mice was significantly reduced. However, AST and AST-DHA supplementation further
242
decreased the expression of ASC protein. Compared with the non-transgenic mice, the expression
243
of Caspase 1 and Pro-IL-1β in APP/PS1 transgenic mice was remarkably increased. Interestingly,
244
AST and AST-DHA supplementation obviously reversed the increase of Caspase 1 and Pro-IL-1β,
245
and AST-DHA exerted more significant effects than AST.
246
AST and AST-DHA Suppressed Apoptosis in APP/PS1 Mice. Western blotting assay was
247
performed to detect the apoptosis-related proteins in APP/PS1 mice (Fig. 8). Unexpectedly, AST
ACS Paragon Plus Environment
Page 10 of 30
Page 11 of 30
Journal of Agricultural and Food Chemistry
248
and AST-DHA supplementation had no corresponding improvement in regulating Bcl-2 and Bax
249
protein expression. The relative densities of Caspase-9 and Caspase-3 in APP/PS1 transgenic mice
250
were remarkably increased compared with the mice in the control group. Following AST and
251
AST-DHA administration, the protein levels of Caspase-9 and Caspase-3 were obviously reduced.
252
Notably, AST-DHA was superior to AST in reducing the protein expressions of Caspase-9/-3. Both
253
AST and AST-DHA could obviously suppress cleaved Caspase-3 expression with a similar degree.
254
DISCUSSION
255
The pathological characteristics of AD brains mainly include extracellular Aβ plaques,
256
intracellular
257
neuro-inflammation 1. APP/PS1 transgenic mouse is one of well-established AD animal model16-17.
258
To illustrate the possibility of false positivity, we determined the efficacy of AST and AST-DHA in
259
8-Arm maze and Morris water maze test in the present study. Both AST and AST-DHA treatment
260
could improve spatial learning ability in APP/PS1 mice by 8-arm maze apparatus, which were
261
further corroborated by the Morris water maze test. The results showed that both AST and
262
AST-DHA could improve the learning and memory skills, in which the AST-DHA was superior to
263
AST in Morris water maze test. The different result of these two behavior tests may be attributed
264
to that 8-Arm maze test is appetitive reinforcement, and Morris water maze test is aversive
265
reinforcement. Furthermore, the learned behavior in these two tests is also different among
266
learning tasks. The Morris water maze test usually learns a spatial task, in which rats have to learn
267
complex behavioral strategies to recognize the platform to escape from water.
268
neurofibrillary
tangles,
massive
neuronal
cell
and
synapse
loss,
and
The accumulation and deposition of Aβ are considered to play an important role in the 18
269
pathogenesis of AD, which is the dominant theory of AD in the past few decades
270
produced by the proteolytic processing of amyloid precursor protein (APP). An important way to
271
process APP is the nonamyloidogenic pathway, in which α-secretase cleaves the Aβ domain in
272
APP, thereby precluding the formation of intact Aβ. However, under normal circumstances, a
273
small amount of APP is processed via the amyloidogenic pathway, in which Aβ is released from
274
APP by β-site amyloid precursor protein cleaving enzyme 1 (BACE1) and γ-secretases. ADAM10
275
and Nicastrin is one of the components of α-secretase and γ-secretases, respectively. Aβ as a
ACS Paragon Plus Environment
. Aβ is
Journal of Agricultural and Food Chemistry
276
monomer readily aggregates to form multimeric complexes 19. These complexes are composed of
277
soluble Aβ ranging from oligomers to protofibrils and insoluble Aβ such as amyloid plaques. The
278
immunohistochemistry results showed that AST-DHA treatment showed better effects than AST in
279
decreasing the number of senile plaques and Aβ plaques load in the cortex and hippocampus of
280
APP/PS1 mice, which was consistent with the results of ELISA kits. Interestingly, AST and
281
AST-DHA only showed notable effects in regulating the expression of Nicastrin instead of
282
BACE1 and ADAM10. The Aβ decrease might partly depend on the clearance mechanism, as it
283
has been reported that n-3 LCPUFAs significantly promoted interstitial Aβ clearance from the
284
brain to resist Aβ injury 20.
285
AST treatment is usually related to the reduced markers of oxidative damage. AST may
286
increase the levels of endogenous antioxidant enzymes including superoxide dismutase and
287
catalase
288
indispensable role of DHA in AST-DHA.
21
. AST-DHA exhibited more effective antioxidant capacity than AST, indicating the
289
Increasing evidence has indicated Aβ induced hyper-phosphorylation of Tau protein by
290
GSK3β activation 22-23. The results showed that AST and AST-DHA significantly decreased p-Tau
291
and p-GSK3β, and AST-DHA was superior to AST. The cognitive improvement of AST-DHA on
292
APP/PS1 transgenic mice are mainly attributed to the neuroprotective effects on GSK3β activation
293
and tau hyper-phosphorylation.
294
Uncontrolled microglia and astrocytes activation, and sustained inflammatory responses may
295
contribute independently to neurodegeneration 24-25. It can not only be a consequence but also be a
296
trigger of pathology
297
APP/PS1 transgenic mice, which was accompanied by a strong increase of TNF-α rather than
298
IL-1β compared with the non-transgenic mice. Following AST and AST-DHA treatment,
299
pro-inflammatory cytokine levels were greatly reduced, especially in the AST-DHA group,
300
indicating that the anti-inflammatory effects of AST and AST-DHA may account for the reduced
301
Aβ level and cognitive improvement in APP/PS1 transgenic mice.
26
. The activation of microglia and astrocytes were found in the brain of
ACS Paragon Plus Environment
Page 12 of 30
Page 13 of 30
Journal of Agricultural and Food Chemistry
302
Neuro-inflammatory cascades depend on the activation of NLRP3 inflammasome, which was 27
303
crucial in neurodegenerative diseases
304
NLRP3 inflammasome, process IL-1β and IL-18, and finally induce AD pathology and tissue
305
damage 28. Moreover, in AD transgenic mouse model, the inhibition of NLRP3 can largely protect
306
memory loss and decrease Aβ deposition. A chronic administration of AST and AST-DHA in
307
APP/PS1 transgenic mice led to a remarkable alteration in NLRP3 inflammasome, in which
308
AST-DHA was superior to AST. The effects of AST and AST-DHA on glial activation and NLRP3
309
inflammasome confirmed the importance of AST-DHA in regulating inflammatory responses.
. It has been proved that the toxicity of Aβ can activate
310
Numerous studies on mitochondria dysfunction revealed that the mitochondria were the
311
central of oxidative stress induced apoptosis29-30. Bcl-2 is an anti-apoptotic protein, while Bax has
312
the opposite function. Caspase-9/-3 are the initiator and executioner, respectively, which typically
313
predominate in neurodegenerative diseases
314
decrease the expression Caspase-9/-3 and cleaved Caspase-3, and the effect of AST-DHA was
315
superior to AST. However, no expected effects of AST and AST-DHA on reducing Bax and
316
improving Bcl-2 were observed in APP/PS1 transgenic mice. Apoptosis is a complex and precisely
317
controlled process, which is regulated by multiple pathways. We speculated that the decreased
318
Caspase-9 and Caspase-3 were not only regulated by the Bcl-2/Bax, other pathways might be
319
related to regulating Caspase family.
31
. Both AST and AST-DHA could significantly
320
In summary, both AST and AST-DHA could improve AD in different degrees. AST-DHA
321
exhibited better actions than AST in improving learning and memory abilities by the behavior
322
experiments. The further mechanical research indicated AST-DHA exerted more remarkable
323
functions than AST on inhibiting Aβ generation, regulating oxidative stress, suppressing the
324
hyperphosphorylation of Tau and GSK-3β, and reducing neuroglial activation and
325
neuro-inflammation (Fig. 9). Therefore, AST and AST-DHA may be applied as food supplements
326
and/or functional ingredients to relieve neurodegenerative disease.
327
Author Information
328
* E-mail:
[email protected]; phone: +86 0532 82032597; fax: +86 0532 82032468
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
329
*E-mail:
[email protected]; phone: +86 0532 82032597; fax: +86 0532 82032468
330
Author contributions
331
Hongxia Che and Qian Li designed and conducted the research. Qian Li, Dan-dan Wang and Lu
332
Yang analyzed the data; Hongxia Che wrote the manuscript; Tian-tian Zhang, Jie Xu and
333
Teruyoshi Yanagita revised the manuscript. Yuming Wang, Changhu Xue and Yaoguang Chang
334
had primary responsibility for the final content. All authors read and approved the final
335
manuscript.
336
Funding
337
This work was supported by grants from State Key Program of National Natural Science of China
338
(No. 31330060) and National Natural Science Foundation of China-Shandong Joint Fund for
339
Marine Science Research Centers (U1606403), and the Fundamental Research Funds for the
340
Central Universities (No. 201762028).
341
Conflicts of interest
342
All the authors declare that there is no conflict of interest for any of them.
343
List of Abbreviations
344
AD, Alzheimer’s disease; AST, Astaxanthin; AST-DHA, Docosahexaenoic acid-acylated AST
345
diesters; APP, amyloid precursor protein; PS1, presenilin; Aβ, β-amyloid; SOD, superoxide
346
dismutase; NOS, inducible nitric oxide synthase; NO, nitric oxide; GFAP, glial fibrillary acidic
347
protein; TNF-α, tumor necrosis factor α; IL-1β, interleukin 1beta; Bcl-2, B-cell lymphoma 2; Bax,
348
Bcl-2-associated X Protein; NLRP3, nucleotide-binding oligomerization domain (NOD)-like
349
receptor containing pyrin domain 3; ASC, apoptosis-associated speck-like protein containing a
350
CARD
ACS Paragon Plus Environment
Page 14 of 30
Page 15 of 30
Journal of Agricultural and Food Chemistry
351
REFERENCES
352
1.
353
Neuroprotective effects of bajijiasu against cognitive impairment induced by amyloid-β in APP/PS1
354
mice. Oncotarget. 2017, 54, 92621.
355
2.
356
and its commercial applications--a review. Mar. Drugs. 2014, 1, 128-52.
357
3.
358
planipes): optical R/S isomers and fatty acid moieties of astaxanthin esters. Comp. Biochem. Phys. B.
359
2002, 3, 437.
360
4.
361
canthaxanthin in raw and smoked Atlantic salmon (Salmo salar) during frozen storage. Food Chem.
362
1998, 3, 313-317.
363
5.
364
with potential in human health and nutrition. J. Nat. Prod. 2006, 3, 443-449.
365
6.
366
heme oxygenase-1 expression through ERK1/2 pathway and its protective effect against
367
beta-amyloid-induced cytotoxicity in SH-SY5Y cells. Brain Res. 2010, 1, 159-167.
368
7.
369
Paula-Lima, A. Astaxanthin Protects Primary Hippocampal Neurons against Noxious Effects of
370
Aβ-Oligomers. Neural. Plast.. 2016, 1, 3456783.
371
8.
372
neurocognitive functions and modulates proteomic changes in brain tissues of d-galactose induced
373
aging mice. Food Funct. 2017, 5, 2038-2045.
374
9.
375
Annu. Rev. Food Sci. T. 2018, 9, 345-381.
Cai, H.; Wang, Y.; He, J.; Cai, T.; Wu, J.; Fang, J.; Zhang, R.; Guo, Z.; Guan, L.; Zhan, Q.
Ambati, R. R.; Moi, P. S.; Ravi, S. Astaxanthin: sources, extraction, stability, biological activities
Coral-Hinostroza, G. N.; Bjerkeng, B. Astaxanthin from the red crab langostilla (Pleuroncodes
Sheehan, E. M.; O'Connor, T. P.; Pja, S.; Buckley, D. J.; Fitzgerald, R. Stability of astaxanthin and
Hussein, G., Sankawa, U., Goto, H., Matsumoto, K., Watanabe, H. Astaxanthin, a carotenoid
Wang, H. Q.; Sun, X. B.; Xu, Y. X.; Zhao, H.; Zhu, Q. Y.; Zhu, C. Q. Astaxanthin upregulates
Lobos, P.; Bruna, B.; Cordova, A.; Barattini, P.; Galaz, J. L.; Adasme, T.; Hidalgo, C.; Munoz, P.;
Cheong, L. Z.; Sun, T.; Li, Y.; Zhou, J.; Lu, C.; Li, Y.; Huang, Z.; Su, X. Dietary krill oil enhances
Shahidi, F.; Ambigaipalan, P. Omega-3 Polyunsaturated Fatty Acids and Their Health Benefits.
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
376
10. Reiserer, R. S.; Harrison, F. E.; Syverud, D. C.; Mcdonald, M. P. Impaired spatial learning in the
377
APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease. Genes Brain Behav. 2007, 1,
378
54-65.
379
11. Xu, Z.; Na, X.; Chen, Y.; Huang, H.; Marshall, C.; Gao, J.; Cai, Z.; Wu, T.; Gang, H.; Ming, X.
380
Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Aβ accumulation and memory deficits.
381
Mol. Neurodegener. 2015, 1, 58.
382
12. Huang, H.; Nie, S.; Cao, M.; Marshall, C.; Gao, J.; Xiao, N.; Hu, G.; Xiao, M. Characterization of
383
AD-like phenotype in aged APPSwe/PS1dE9 mice. Age. 2016, 4, 1-20.
384
13. Yang, L.; Xuemin, L. I.; Zhou, Q.; Zhaojie, L. I.; Jie, X. U.; Xue, C. Synthesis and Mass
385
Spectrometry Analysis of Docosahexaenoic Acid Astaxanthin Ester. Food Sci. 2017, 2, 220-226.
386
14. Enomoto, T.; Ishibashi, T.; Tokuda, K.; Ishiyama, T.; Toma, S.; Ito, A. Lurasidone reverses
387
MK-801-induced impairment of learning and memory in the Morris water maze and radial-arm maze
388
tests in rats. Behav. Brain res. 2008, 2, 197.
389
15. Che, H.; Zhou, M.; Zhang, T.; Zhang, L.; Ding, L.; Yanagita, T.; Xu, J.; Xue, C.; Wang, Y.
390
Comparative study of Phosphatidylcholine rich in DHA or EPA on Alzheimer's Disease and the
391
possible involved mechanisms in CHO-APP/PS1 cell and SAMP8 mice. Food Funct. 2017, 2, 197-207.
392
16. Deng, M.; Huang, L.; Ning, B.; Wang, N.; Zhang, Q.; Zhu, C.; Fang, Y. β-asarone improves
393
learning and memory and reduces Acetyl Cholinesterase and Beta-amyloid 42 levels in APP/PS1
394
transgenic mice by regulating Beclin-1-dependent autophagy. Brain Res. 2016, 1652, 188-194.
395
17. Jiang, T.; Yu, J. T.; Zhu, X. C.; Tan, M. S.; Wang, H. F.; Cao, L.; Zhang, Q. Q.; Shi, J. Q.; Gao, L.;
396
Qin, H. Temsirolimus promotes autophagic clearance of amyloid-β and provides protective effects in
397
cellular and animal models of Alzheimer's disease. Pharmacol. Res. 2014, 81, 54-63.
398
18. Takahashi, R. H.; Nagao, T.; Gouras, G. K. Plaque formation and the intraneuronal accumulation
399
of β-amyloid in Alzheimer's disease. Pathology. International. 2017, 4, 185.
400
19. Riqiang Yan, R. V. Targeting the β secretase BACE1 for Alzheimer's disease therapy. Lancet
401
Neurology. 2014, 3, 319-29.
ACS Paragon Plus Environment
Page 16 of 30
Page 17 of 30
Journal of Agricultural and Food Chemistry
402
20. Ren, H.; Luo, C.; Feng, Y.; Yao, X.; Shi, Z.; Liang, F.; Kang, J. X.; Wan, J. B.; Pei, Z.; Su, H.
403
Omega-3 polyunsaturated fatty acids promote amyloid-β clearance from the brain through mediating
404
the function of the glymphatic system. Faseb J. 2017, 1, 282.
405
21. Grimmig, B.; Kim, S. H.; Nash, K.; Bickford, P. C.; Shytle, R. D. Neuroprotective mechanisms of
406
astaxanthin: a potential therapeutic role in preserving cognitive function in age and neurodegeneration.
407
Geroscience. 2017, 1, 1-14.
408
22. Vossel, K. A.; Xu, J. C.; Fomenko, V.; Miyamoto, T.; Suberbielle, E.; Knox, J. A.; Ho, K.; Kim, D.
409
H.; Yu, G. Q.; Mucke, L. Tau reduction prevents Aβ-induced axonal transport deficits by blocking
410
activation of GSK3β. J. Cell. Biol. 2015, 3, 419-433.
411
23. Simic, G.; Leko, M. B.; Wray, S.; Harrington, C.; Delalle, I.; Natasa, J. M.; Bazadona, D.; Buee,
412
L.; Silva, R. D.; Giovanni, G. D.; Wischik, C. Tau Protein Hyperphosphorylation and Aggregation in
413
Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies. Biomol. 2016, 1,
414
6.
415
24. Heppner, F. L.; Ransohoff, R. M.; Becher, B. Immune attack: the role of inflammation in
416
Alzheimer disease. Nat. Rev. Neurosci. 2015, 6, 358-72.
417
25. McGeer, E. G.; McGeer, P. L. Inflammatory processes in Alzheimer's disease. Prog.
418
Neuro-Psychoph. 2003, 5, 741-749.
419
26. Liao, W.; Liu, Z.; Zhang, T.; Sun, S.; Ye, J.; Li, Z.; Mao, L.; Ren, J. Enhancement of
420
Anti-Inflammatory Properties of Nobiletin in Macrophages by a Nano-Emulsion Preparation. J. Agr.
421
Food Chem. 2017, 1, 91-98.
422
27. Zhou, K.; Shi, L.; Wang, Y.; Chen, S.; Zhang, J. Recent Advances of the NLRP3 Inflammasome in
423
Central Nervous System Disorders. J. Immunol. Res. 2016, 2, 1-9.
424
28. Tan, M. S.; Yu, J. T.; Jiang, T.; Zhu, X. C.; Tan, L. The NLRP3 inflammasome in Alzheimer's
425
disease. Mol. neurobio. 2013, 3, 875-82.
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
426
29. Liao, W.; Lai, T.; Chen, L.; Fu, J.; Sreenivasan, S. T.; Yu, Z.; Ren, J. Synthesis and
427
Characterization of a Walnut Peptides Zinc Complex and Its Antiproliferative Activity against Human
428
Breast Carcinoma Cells through the Induction of Apoptosis. J. Agr. Food Chem. 2016, 7, 849-859.
429
30. Liao, W.; Zhang, R.; Dong, C.; Yu, Z.; Ren, J. Novel walnut peptide-selenium hybrids with
430
enhanced anticancer synergism: facile synthesis and mechanistic investigation of anticancer activity. Int.
431
J. Nanomed. 2016, 11, 1305-1321.
432
31. Che, H.; Fu, X.; Zhang, L.; Xiang, G.; Min, W.; Lei, D.; Xue, C.; Jie, X.; Wang, Y.
433
Neuroprotective Effects of n-3 Polyunsaturated Fatty Acid-Enriched Phosphatidylserine Against
434
Oxidative Damage in PC12 Cells. Cell. Mol. Neurobio. 2017, 1-12.
ACS Paragon Plus Environment
Page 18 of 30
Page 19 of 30
Journal of Agricultural and Food Chemistry
435
Figure Captions
436
Fig.1 Structure and effects of AST and AST-DHA on spatial learning and memory deficiency.
437
Structure of AST and AST-DHA (A). The number of reference memory errors in radial 8-Arm
438
maze (B), number of working memory errors in radial 8-Arm maze (C). Time needed to reach the
439
hidden platform in the Morris maze (D). The time spent in the target quadrant. (E) and the number
440
of crossing platform (F) were measured for analysis of spatial memory function. Data were
441
presented as mean ± SD (n = 8), *P< 0.05 was considered statistically significant. Different letters
442
indicated significant difference between each group.
443
Fig.2 Represent photo and quantitative analysis of amyloid plaques in cortex and hippocampus of
444
APP/PS1 transgenic mice (A). Plaques number of Aβ in cortex and hippocampus (B). Relative of
445
quantitative analysis of Aβ load in cortex and hippocampus (C). Scale bar = 100 µm.
446
Fig.3 Effects of AST and AST-DHA on the regulation of Aβ concentration in APP/PS1 transgenic
447
mice. Levels of insoluble Aβ40 (A), soluble Aβ40 (B), insoluble Aβ42 (C) and soluble Aβ42 (D)
448
were measured by ELISA. Representative western blots (E) and densitometry of ADAM10 (F),
449
BACE1 (G) and Nicastrin (H). Data were presented as mean ± SD (n=8); *P< 0.05 was
450
considered statistically significant. Different letters indicated significant difference between each
451
group.
452
Fig.4 Effects of AST and AST-DHA on the SOD activity (A), NO concentration (B) and NOS
453
activity (C) in brain. Data were expressed as mean± SD (n = 8), *P< 0.05 was considered
454
statistically significant. Different letter indicated significant difference between each group.
455
Fig.5. Effects of AST and AST-DHA on tau and GSK-3β hyper-phosphorylation. (A) Western
456
blot analysis of p-GSK3β and p-Tau. Densitometry analysis of p-GSK3β (B) and p-Tau (C).
457
Values were indicated as the mean ± SD (n = 8), *P< 0.05 was considered statistically significant.
458
Different letter indicated significant difference between each group APP/PS1 transgenic mice.
459
Fig.6 Effects of AST and AST-DHA on neuroglial activation and neuro-inflammation. (A) Effects
460
of AST and AST-DHA on glial markers were analyzed by immunohistochemistry mmunostaining
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
461
of the microglial marker Iba1astroglial marker GFAP and the Scale bar = 10 µm. (B) Western blot
462
analysis of CD11b, GFAP, IL-1β and TNF-α. Densitometry analysis of CD11b (C), GFAP (D),
463
IL-1β (E) and TNF-α (F). Values were indicated as the mean ± SD (n = 8), *p< 0.05 was
464
considered statistically significant. Different letter indicated significant difference between each
465
group.
466
Fig.7 Effects of AST and AST-DHA on inflammasome expression and activation. (A) Western
467
blot analysis of NLPR3, ASC, Caspase 1 and Pro-IL-1β. Densitometry analysis of NLRP3 (B),
468
ASC (C), Caspase 1 (D), and Pro-IL-1β (D). Values were indicated as the mean ± SD (n = 8), *p